Dholakia, Jhalak http://orcid.org/0000-0002-1813-8820
Cohen, Alexander C.
Leath, Charles A. III
Evans, Elizabeth T.
Alvarez, Ronald D.
Thaker, Premal H.
Funding for this research was provided by:
National Cancer Institute (UG1 CA23330)
National Institutes of Health (P50 CA098252)
Article History
Accepted: 8 November 2021
First Online: 10 February 2022
Declarations
:
: Jhalak Dholakia declares that she has no conflict of interest. Alexander C. Cohen declares that he has no conflict of interest. Charles A. Leath III declares that he has no conflict of interest. Elizabeth T. Evans declares that she has no conflict of interest. Ronald D. Alvarez declares that he has no conflict of interest. Premal H. Thaker has received research funding (paid to her institution) from Merck and GlaxoSmithKline; has received compensation for service as a consultant from Celsion; has received speaker’s honoraria from GlaxoSmithKline and AstraZeneca; has participated on Data Safety Monitoring or advisory boards for Iovance Biotherapeutics, Novocure, Celsion, Agenus, Eisai, GlaxoSmithKline, and Seagen; and owns stock/stock options in Celsion.